SI-BONE, Inc. (NASDAQ:SIBN) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lessened its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 31.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 454,975 shares of the company's stock after selling 209,531 shares during the quarter. Dimensional Fund Advisors LP owned about 1.10% of SI-BONE worth $5,882,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of SIBN. Champlain Investment Partners LLC lifted its stake in shares of SI-BONE by 104.8% during the first quarter. Champlain Investment Partners LLC now owns 2,453,147 shares of the company's stock valued at $40,158,000 after buying an additional 1,255,610 shares during the period. Bellevue Group AG lifted its stake in shares of SI-BONE by 810.5% during the 1st quarter. Bellevue Group AG now owns 1,139,956 shares of the company's stock worth $18,661,000 after purchasing an additional 1,014,756 shares during the period. American Century Companies Inc. boosted its holdings in shares of SI-BONE by 22.8% during the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company's stock worth $25,685,000 after purchasing an additional 368,637 shares during the last quarter. Wellington Management Group LLP grew its position in shares of SI-BONE by 34.9% in the fourth quarter. Wellington Management Group LLP now owns 817,048 shares of the company's stock valued at $17,150,000 after purchasing an additional 211,209 shares during the period. Finally, Pier Capital LLC grew its position in shares of SI-BONE by 80.7% in the second quarter. Pier Capital LLC now owns 377,001 shares of the company's stock valued at $4,875,000 after purchasing an additional 168,417 shares during the period. Hedge funds and other institutional investors own 98.11% of the company's stock.

SI-BONE Trading Down 4.5 %

Shares of NASDAQ SIBN traded down $0.61 during midday trading on Wednesday, hitting $12.84. The stock had a trading volume of 597,408 shares, compared to its average volume of 385,580. The company has a fifty day moving average price of $14.83 and a 200 day moving average price of $14.63. The company has a market capitalization of $529.07 million, a price-to-earnings ratio of -11.78 and a beta of 1.22. SI-BONE, Inc. has a 1-year low of $11.76 and a 1-year high of $21.70. The company has a quick ratio of 8.12, a current ratio of 9.17 and a debt-to-equity ratio of 0.22.

SI-BONE (NASDAQ:SIBN - Get Free Report) last announced its quarterly earnings results on Monday, August 5th. The company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.26) by $0.04. The firm had revenue of $39.97 million for the quarter, compared to analysts' expectations of $38.95 million. SI-BONE had a negative net margin of 27.10% and a negative return on equity of 24.27%. During the same period in the previous year, the company posted ($0.30) earnings per share. On average, analysts predict that SI-BONE, Inc. will post -0.89 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have issued reports on SIBN shares. Needham & Company LLC decreased their price target on SI-BONE from $27.00 to $19.00 and set a "buy" rating on the stock in a research note on Tuesday, August 6th. Truist Financial decreased their target price on shares of SI-BONE from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Tuesday, August 6th. Finally, Morgan Stanley dropped their price target on shares of SI-BONE from $21.00 to $19.00 and set an "overweight" rating for the company in a research report on Tuesday, August 6th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $23.00.

Insider Buying and Selling at SI-BONE

In other news, insider Anthony J. Recupero sold 2,087 shares of SI-BONE stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $14.17, for a total transaction of $29,572.79. Following the sale, the insider now directly owns 236,717 shares of the company's stock, valued at approximately $3,354,279.89. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Anthony J. Recupero sold 2,087 shares of the firm's stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $14.17, for a total transaction of $29,572.79. Following the completion of the sale, the insider now owns 236,717 shares of the company's stock, valued at approximately $3,354,279.89. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Anthony J. Recupero sold 3,905 shares of the company's stock in a transaction on Friday, August 16th. The shares were sold at an average price of $13.84, for a total transaction of $54,045.20. Following the completion of the sale, the insider now directly owns 238,804 shares in the company, valued at $3,305,047.36. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,019 shares of company stock valued at $349,879 in the last ninety days. Insiders own 5.40% of the company's stock.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.